PVLA
Palvella Therapeutics Inc
NASDAQ · Biotechnology
$82.20
+5.77 (+7.55%)
Open$78.93
Previous Close$76.43
Day High$85.05
Day Low$78.93
52W High$114.69
52W Low$14.60
Volume—
Avg Volume314.0K
Market Cap972.96M
P/E Ratio—
EPS$-3.81
SectorBiotechnology
Analyst Ratings
Strong Buy
21 analysts
Price Target
-35.8% upside
Current
$82.20
$82.20
Target
$52.81
$52.81
$42.56
$52.81 avg
$76.13
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 450.02M | 396.70M | 170.23M |
| Net Income | -90,233,119 | -71,588,334 | 29.11M |
| Profit Margin | -57.3% | -54.5% | 17.1% |
| EBITDA | -90,233,119 | -75,565,464 | 47.11M |
| Free Cash Flow | — | — | 10.70M |
| Rev Growth | +13.4% | +13.4% | -3.6% |
| Debt/Equity | 0.19 | 0.19 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |